THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

KENNEDY CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000884589)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024

Shares 39,526 Value ($000) $335 Avg Close $9.03 Range $8.13 - $10.44

Q1 2024

Shares 38,202 Value ($000) $343 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 36,843 Value ($000) $414 Avg Close $10.06 Range $8.52 - $11.57

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2024	39,526	$335	$9.03	$8.13 - $10.44
Q1 2024	38,202	$343	$9.27	$8.21 - $11.71
Q4 2023	36,843	$414	$10.06	$8.52 - $11.57